Browse by Clinical Topic:

Featured CME/CE Content:
neuroscienceCME Editors' Picks:

Health Inequities in Obesity Care

Premiere Date: Friday, December 30, 2022

This activity offers CE credit for:

  1. ABIM (MOC)
  2. ABS (CC)
  3. Medicine (accme)
  4. Nursing (ANCC)
  5. Pharmacy (acpe)
  6. PA (aapa)
  7. Dietetic Registration (CDR)
  8. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Tuesday, December 30, 2025


Monica E. Peek, MD, MPH, MScMonica E. Peek, MD, MPH, MSc (Moderator)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, IL

Nijya Noble, MS, RDN, LDNijya Noble, MS, RDN, LD 
CEO of NK Fitness and Nutrition
Reynoldsburg, OH

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOSFatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS 
Associate Professor of Medicine and Pediatrics
Obesity Medicine Physician Scientist
Massachusetts General Hospital
Boston, MA

Statement of Need

Both the American Medical Association and American Association of Clinical Endocrinologists (AACE) now recognize obesity as a disease characterized by multiple pathophysiologic aspects that require a range of interventions for treatment and prevention. As if this weren’t challenging enough, patients with obesity from many underserved communities have an even greater hurdle: how to receive equitable care when so many factors, including social determinants of health, are stacked against them.

For clinicians, step one is helping patients to realize their difficulty with losing weight and keeping it off is not their fault from being lazy or undisciplined. Indeed, several pathophysiologic/hormonal forces within an individual’s body conspire to regain any weight loss that may have been achieved. Step 2 is for clinicians to dig deep and reflect on potential personal and/or institutional biases that negatively impact the care they provide. And step 3 is to partner with patients to help them overcome barriers to receiving and adhering to equitable, evidence-based care.

In this installment of the popular CMEO podcast series on diversity, equity, and inclusion (DEI), Drs. Peek, Stanford, and Noble discuss the influence of implicit bias, health disparities, and health inequities on the quality of care for patients with obesity. Practical approaches to self-reflection, recognition of potential bias, and positive action are explored.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Analyze the influence of unconscious bias, health disparities, and health inequities on obesity care.

Financial Support

Supported by an educational grant from Johnson & Johnson.

Target Audience

Physicians, PAs, NPs, nurses, pharmacists, and dieticians specializing in primary care, endocrinology, surgery, or internal medicine.

Credit Information

ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats
Enduring material

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Peek reports the following financial relationships:

Consultant: Pfizer Inc.

Ms. Noble reports no financial relationships to disclose.

Dr. Stanford reports the following financial relationships:

Advisory Board: Alfie; Calibrate Health; Coral Health Inc.; GoodRx, Inc.; and Veri

Consultant: Boehringer Ingelheim GmbH; Eli Lilly and Company; Gelesis; Novo Nordisk; and Pfizer Inc.

The following peer reviewer and CME Outfitters staff have no financial relationships:
  • Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)
  • Meghann Taft-Lockard (planning committee)
  • Warren Beckman (planning committee)
  • Evan Luberger (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

  • Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

    Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


    Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download